In EU/EEA countries, a sharp increase was observed in respiratory syncytial virus (RSV) activity, marking the start of the epidemic wave. Influenza and SARS-CoV-2 activities remained at low levels.
In EU/EEA countries, a sharp increase was observed in respiratory syncytial virus (RSV) activity, marking the start of the epidemic wave. Influenza and SARS-CoV-2 activities remained at low levels.